Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 2
2018 6
2019 4
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients.
Kieler M, Unseld M, Bianconi D, Schindl M, Kornek GV, Scheithauer W, Prager GW. Kieler M, et al. Among authors: bianconi d. J Clin Med. 2020 Feb 28;9(3):648. doi: 10.3390/jcm9030648. J Clin Med. 2020. PMID: 32121198 Free PMC article.
Integrins in the Spotlight of Cancer.
Bianconi D, Unseld M, Prager GW. Bianconi D, et al. Int J Mol Sci. 2016 Dec 6;17(12):2037. doi: 10.3390/ijms17122037. Int J Mol Sci. 2016. PMID: 27929432 Free PMC article. Review.
Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer.
Kieler M, Unseld M, Bianconi D, Prager GW. Kieler M, et al. Among authors: bianconi d. Memo. 2017;10(3):136-140. doi: 10.1007/s12254-017-0352-2. Epub 2017 Sep 7. Memo. 2017. PMID: 28989542 Free PMC article. Review.
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity Cycle.
Kieler M, Unseld M, Bianconi D, Prager G. Kieler M, et al. Among authors: bianconi d. Pancreas. 2018 Feb;47(2):142-157. doi: 10.1097/MPA.0000000000000970. Pancreas. 2018. PMID: 29346215 Review.
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients.
Unseld M, Fischöder S, Jachs M, Drimmel M, Siebenhüner A, Bianconi D, Kieler M, Puhr H, Minichsdorfer C, Winder T, Prager GW. Unseld M, et al. Among authors: bianconi d. J Clin Med. 2020 Jun 7;9(6):1772. doi: 10.3390/jcm9061772. J Clin Med. 2020. PMID: 32517383 Free PMC article.
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI.
Kieler M, Unseld M, Bianconi D, Waneck F, Mader R, Wrba F, Fuereder T, Marosi C, Raderer M, Staber P, Berger W, Sibilia M, Polterauer S, Müllauer L, Preusser M, Zielinski CC, Prager GW. Kieler M, et al. Among authors: bianconi d. ESMO Open. 2019 Jul 17;4(4):e000538. doi: 10.1136/esmoopen-2019-000538. eCollection 2019. ESMO Open. 2019. PMID: 31423337 Free PMC article.
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.
Kieler M, Unseld M, Bianconi D, Scheithauer W, Prager GW. Kieler M, et al. Among authors: bianconi d. Ther Adv Med Oncol. 2019 Jul 17;11:1758835919853196. doi: 10.1177/1758835919853196. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31360237 Free PMC article.
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology.
Prager GW, Unseld M, Waneck F, Mader R, Wrba F, Raderer M, Fuereder T, Staber P, Jäger U, Kieler M, Bianconi D, Hoda MA, Baumann L, Reinthaller A, Berger W, Grimm C, Kölbl H, Sibilia M, Müllauer L, Zielinski C. Prager GW, et al. Among authors: bianconi d. Oncotarget. 2019 Jan 29;10(9):942-952. doi: 10.18632/oncotarget.26604. eCollection 2019 Jan 29. Oncotarget. 2019. PMID: 30847023 Free PMC article.
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
Bianconi D, Herac M, Posch F, Schmeidl M, Unseld M, Kieler M, Brettner R, Müllauer L, Riedl J, Gerger A, Scheithauer W, Prager G. Bianconi D, et al. Ther Adv Med Oncol. 2020 Aug 18;12:1758835920928635. doi: 10.1177/1758835920928635. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32922518 Free PMC article.
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.
Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager GW. Bianconi D, et al. Transl Oncol. 2019 Jan;12(1):15-23. doi: 10.1016/j.tranon.2018.08.019. Epub 2018 Sep 20. Transl Oncol. 2019. PMID: 30245304 Free PMC article.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback